Clinical trial
Evaluating the Therapeutic Effect of Pentoxifylline and Zinc Co-administration in Patients With Idiopathic Oligoasthenoteratozoospermia
NCT05156684 is registered in ClinicalTrials.gov with Arak University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Therapeutic Effect of Pentoxifylline and Zinc Co-administration in Patients With Idiopathic Oligoasthenoteratozoospermia
- Lead sponsor
- Arak University of Medical Sciences
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 1, 2022
- Completion date
- May 28, 2022
- Enrollment
- 140 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
idiopathic infertility